BIANCA BRAXTON: Open Payments
NPI 1952765554 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 41 payments from 15 companies in 2025. Trend: 2023 $1,209 · 2024 $1,809 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $242 |
| AstraZeneca Pharmaceuticals LP | 7 | $231 |
| Paratek Pharmaceuticals, Inc. | 3 | $141 |
| Amgen Inc. | 8 | $141 |
| Lilly USA, LLC | 3 | $70 |
| PFIZER INC. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| ABBVIE INC. | 1 | $33 |
| Organon LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: AIRSUPRA, Ozempic, NUZYRA, OTEZLA, MOUNJARO, EVENITY, PREVNAR 20, JARDIANCE.
Industry payments across OK — which companies pay providers there.
